FDA Adverse Event Malfunction Summary report: N

A1A-2000

MDR report key: 7410138 · Received April 9, 2018

Report

Report Number
8031673-2018-04952
Event Type
Malfunction
Date Received
April 9, 2018
Date of Event
February 27, 2017
Report Date
April 9, 2018
Manufacturer
TOSOH CORPORATION
Product Code
KHO
PMA / PMN Number
K0971103
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

TOSOH BIOSCIENCE, INC. IS SUBMITTING ON BEHALF OF THE FOREIGN MANUFACTURER, TOSOH CORPORATION, PER EXEMPTION NUMBER E2017013. THIS REPORT IS BEING SUBMITTED DUE TO A RETROSPECTIVE REVIEW CONDUCTED UNDER CAPA-2017-0007. SUBMISSION OF THIS REPORT DOES NOT CONSTITUTE AN ADMISSION THAT THE IMPORTER OR MANUFACTURER'S PRODUCT CAUSED OR CONTRIBUTED TO THE EVENT. ON 27-FEB-2017, FSE ARRIVED AT THE SITE TO ADDRESS THE REPORTED EVENT. HE VERIFIED THE PROBLEM, THEN ASSISTED THE CUSTOMER WITH TROUBLESHOOTING. NEXT, FSE REPLACED THE SORTER BOARD, RECHECKED SORTER ALIGNMENTS, AND PERFORMED THE TIP PICKUP MACRO PROGRAM. NO FURTHER ISSUES WERE REPORTED ON 02-MAR-2017, FSE RETURNED TO THE SITE TO REPLACE THE SORTER VALVE & FILTERS, AND CHECK THE VACUUM TUBING FOR RESTRICTION. HE WAS SUBSEQUENTLY ABLE TO SUCCESSFULLY PERFORM THE CORNER TIP MACRO. NO FURTHER ACTION WAS REQUIRED BY FIELD SERVICE. THE MOST PROBABLE CAUSE OF THE REPORTED EVENT WAS DUE TO FAULT/ FAILURE OF THE SORTER BOARD.

Description of Event or Problem · 0

ON (B)(6) 2017, THE CUSTOMER REPORTED INTERMITTENT TIP ISSUES WITH THEIR A1A-2000ST. ON (B)(6) 2017, A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO ADDRESS THE REPORTED EVENT, WHICH MAY HAVE RESULTED IN DELAYED REPORTING OF BHCG, MYO AND CTNL2 PATIENT RESULTS. THERE WAS NO INDICATION OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE POTENTIAL DELAY IN REPORTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
250923 A1A-2000 A1A-2000 KHO TOSOH CORPORATION A1A-2000

Patients

Seq Age Sex Outcome Treatment
1